RAPT Therapeutics (RAPT) Other Gross PP&E Adjustments (2020 - 2024)
Historic Other Gross PP&E Adjustments for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $7.4 million.
- Therapeutics' Other Gross PP&E Adjustments rose 3276.45% to $7.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $7.4 million, marking a year-over-year increase of 3276.45%. This contributed to the annual value of $349000.0 for FY2023, which is 161739.13% up from last year.
- Per Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at $7.4 million for Q3 2024, which was up 3276.45% from $6.9 million recorded in Q2 2024.
- In the past 5 years, Therapeutics' Other Gross PP&E Adjustments registered a high of $10.0 million during Q1 2021, and its lowest value of -$23000.0 during Q4 2022.
- Over the past 5 years, Therapeutics' median Other Gross PP&E Adjustments value was $6.9 million (recorded in 2024), while the average stood at $6.5 million.
- Per our database at Business Quant, Therapeutics' Other Gross PP&E Adjustments plummeted by 10028.42% in 2022 and then skyrocketed by 161739.13% in 2023.
- Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $8.8 million in 2020, then fell by 7.93% to $8.1 million in 2021, then crashed by 100.28% to -$23000.0 in 2022, then surged by 1617.39% to $349000.0 in 2023, then skyrocketed by 2017.77% to $7.4 million in 2024.
- Its last three reported values are $7.4 million in Q3 2024, $6.9 million for Q2 2024, and $6.6 million during Q1 2024.